According to a study by the Indian Medical Research Council (ICMR), a vaccine that has been used to treat tuberculosis for almost a century may help lower the risk of COVID-19 infections in older persons. According to the researchers, BCG immunisation may provide protection against viral infections of the respiratory system. BCG vaccination did not cause hyper-inflammation, but it did cause a down-modulation of basic immune response. It's plausible that BCG vaccination has no effect on pathogen-specific immune responses, or even enhances them, according to the researchers. According to the researchers, a better understanding of the findings could help support clinical effectiveness and explore new BCG vaccination possibilities.

Source: dna August 10, 2021 05:49 UTC